Meanwhile, it has been demonstrated that miRNA-139 could bind to its target gene igf1r (insulin-like growth factor receptor type 1) to regulate the PI3K/AKT signaling pathway, which in turn controls the proliferation and spread of malignant melanoma cells [28]. The gene discussed is AKT1; the disease is melanoma.